Risk factors for severe respiratory syncytial virus infection in infants

Respiratory Medicine

Volumn 96, Issue SUPPL. 2, 2002, Pages S9-

  Aujard, Y ^a,b   Fauroux, B ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Bronchopulmonary dysplasia; Congenital heart disease; Cystic fibrosis; Infants; Palivizumab; Prematurity; Respiratory syncytial virus

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; PALIVIZUMAB; RIBAVIRIN;

CONGENITAL HEART DISEASE; CROWDING; CYSTIC FIBROSIS; DAY CARE; DISEASE SEVERITY; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INFANT DISEASE; INFECTION CONTROL; INFECTION RISK; LUNG DYSPLASIA; PASSIVE SMOKING; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; VIRUS INFECTION; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; INFANT; NEWBORN; PRESCHOOL CHILD; VIROLOGY;

ABNORMALITIES; BRONCHOPULMONARY DYSPLASIA; CHILD, PRESCHOOL; CYSTIC FIBROSIS; HEART DEFECTS, CONGENITAL; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RISK FACTORS;

EID: 10844243106     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2002.1295     Document Type: Article

References (38)

1. Cunningham CK, McMillan JA, Gross SJ. Rehospitalization for respiratory illness in infants of less than 32 weeks' gestation. Pediatrics 1991; 88: 527-532.
2. de Sierra TM, Kumar ML, Wasser TE, et al. Respiratory syncytial virus-specific immunoglobulins in preterm infants. J Pediatr 1993; 122: 787-791.
3. Hodson WA. Normal and abnormal structural development of the lung. In: Polin RA, Fox WW, eds. Fetal and Neonatal Physiology 2nd edn. Philadelphia: WB Saunders Co., 1997; 771-789.
4. Glezen WP, Paredes A, Allison JE, et al. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981; 98: 708-715.
5. Joffe S, Escobar GJ, Black SB, et al. Rehospitalization for respiratory syncytial virus among premature infants. Pediatrics 1999; 104: 894-899.
6. Simoes EAF, King SJ, Lehr MV, et al. Preterm twins and triplets. A high-risk group for severe respiratory syncytial virus infection. Am J Dis Child 1993; 147: 303-306.
7. Carbonell-Estrany X, Quero J, Bustos G, et al. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: A prospective study. Pediatr Infect Dis J 2000; 19: 592-597
8. McConnochie KM, Roghmann KJ. Parental smoking, presence of older siblings, and family history of asthma increase risk of bronchiolitis. Am J Dis Child 1986; 140: 806-812.
9. Abman SH, Ogle JW, Butler-Simon N, et al. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr 1988; 113: 826-830.
10. Arnold SR, Wang EEL, Law BJ, et al. Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: A review of the PICNIC RSV database. Pediatr Infect Dis J 1999; 18: 866-869.
11. Boyce TG, Mellen BG, Mitchel Jr. EF, et al. Rates of hospitalization for respiratory syncytial virus infections among children in Medicaid. J Pediatr 2000; 137: 865-870.
12. DiVincenzo JP. Respiratory syncytial virus infections in hematopoietic stem cell transplant recipients and other severely immunocompromised patients. Pediatr Pathol Mol Med 2000; 19: 115-132.
13. MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982; 307: 397-400.
14. Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997; 102(3A): 2-9.
15. Hiatt PW, Grace SC, Kozinetz CA, et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999; 203: 619-626.
16. Hall CB. Nosocomial respiratory syncytial virus infections: The "cold war" has not ended. Clin Infect Dis 2000; 31: 590-596.
17. Groothuis JR, Gutierrez KM, Bauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 1988; 82: 199-203
18. Li YF, Gilliland FD, Berhane K, et al. Effects of in utero and environmental tobacco smoke exposure on lung function in boys and girls with and without asthma. Am J Respir Crit Care Med 2000; 162: 2097-2104.
19. Tager IB, Ngo L, Hanrahan JP. Maternal smoking during pregnancy. Effects on lung function during the first 18 months of life. Am J Respir Crit Care Med 1995; 152: 977-983.
20. Henderson FW, Collier AM, Clyde WA, et al. Respiratory-syncytial-virus infections, reinfections and immunity. New Engl J Med 1979; 300: 530-534.
21. Behrendt CE, Decker MD, Burch DJ, Watson PH for the International RSV Study Group. International variation in the management of infants hospitalized with respiratory syncytial virus. Eur J Pediatr 1998; 157: 215-220.
22. Julious SA. There is still a seasonally in sudden infant death syndrome in England and Wales. J Epidemiol Comm Health 1997; 51: 101-102.
23. Hall CB. Respiratory syncytial virus. In: Feigen and Cherry, eds. Textbook of Pediatric Infectious Diseases. Philadelphia. WB Saunders Co. 1998.
24. Ballow M, Cates L, Rowe JC, Goetz C, Desbonnet C. Development of the immune system in very tow birth weight (less than 1500 g) premature infants: Concentrations of plasma immunoglobulins and patterns of infections. Pediatr Res 1986; 20: 899-904.
25. Mussi-Pinhata MM, Gonçalves AL. Serum immunoglobulin levels and incidence of infection during the first year of life in full-term and preterm infants. J Tropical Ped 1989; 35: 147-153.
26. Saxon A, Steihm ER. In: Steihm ER, ed. Immunologic Disorders in Infants and Children, 3rd edn. Philadelphia: WB Saunders Co., 1989.
27. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr 1992; 121: 348-354.
28. Wang EE, Prober CG, Manson B, Corey M, Levison H. Association of respiratory viral infections with pulmonary deterioration in patients with cystic fibrosis. N Engl J Med. 1984; 311: 1653-1658.
29. Collinson J, Nicholson KG, Cancio E, et al. Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax 1996; 51: 1115-1122.
30. Armstrong D, Grimwood K, Carlin JB, et al. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonci 1998; 26: 371-379.
31. Ljungman P. Respiratory virus infections in bone marrow transplant recipients: The European perspective. Am J Med 1997; 102(3A): 44-47
32. Chandwani S, Borkowsky W, Krasinski K, Lawrence R, Welliver R. Respiratory syncytial virus infection in human immunodeficiency virus-infected children. J Pediatr 1990; 117: 251-254.
33. Ko JP, Shepard JA, Sproule MW et al. CT manifestations of respiratory syncytial virus infection in lung transplant recipients. J Comput Assist Tomogr 2000; 24: 235-241.
34. Groothuis JR, Salbenblatt CK, Lauer BA. Severe respiratory syncytial virus infection in older children. Am J Dis Child 1990; 144: 346-348.
35. Ariagno RL, Groothuis JR, Kimpen JLL. Treatment and prevention of respiratory syncytial virus disease. Infect Med 1999; 16(Supplement G): 18-28.
36. Simoes EAF. Treatment and prevention of respiratory syncytial virus lower respiratory tract infections. Long-term effects on respiratory outcomes. Am J Respir Crit Care Med 2001; 163: S14-S17.
37. Adcock PM, Sanders CL, Marshall GS. Standardizing the care of bronchiolitis. Arch Pediatr Adolesc Med 1998; 152: 739-744.
38. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduced hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531-537.